News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
J&J invests $1B to expand contact lens manufacturing in Florida
Johnson & Johnson is committing $1 billion to boost contact lens production capacity at its Florida facility. The expansion targets manufacturing, packaging, and distribution to meet rising demand.
IRhythm hit by cyberattack demanding ransom for stolen data
Cardiac monitoring company IRhythm disclosed that attackers stole data from third-party apps and are demanding payment to prevent public release. What we know about the breach.
Centene offers buyouts to 61,000 staff as health plan losses mount
Centene is offering voluntary separation packages to most of its 61,000 employees amid membership declines. The insurer says the program won't amount to a complete overhaul—here's what that means for the business.
Medicare to cover TAVR for asymptomatic aortic stenosis in CMS study
CMS proposed expanding Medicare coverage to include patients with severe aortic valve disease who show no symptoms, contingent on enrollment in an approved clinical trial. Here's what changes for eligible beneficiaries.
Express Scripts sues to block Tennessee PBM breakup law
Express Scripts and pharmacy benefit managers are challenging Tennessee's FAIR Rx Act in court, following CVS Caremark's lawsuit against the same state law passed earlier this year.
iRhythm cardiac data stolen in cyberattack; ransom demanded
Cardiac monitoring company iRhythm disclosed a breach affecting third-party applications. A threat actor is demanding payment to prevent public release of stolen data.
Enzymatic DNA synthesis speeds up biotech production
Fierce Biotech's eBook examines how enzymatic DNA synthesis is improving speed and accuracy for biotech, pharma, and agriculture applications. Learn what's changed in the lab.
Biotech turned failed trial into AI model — here's how
A biotech startup salvaged a failed clinical trial by converting trial data into an AI model. The approach offers a path forward for companies facing setbacks in drug development.
Abridge Claims 'Patient-Centered' AI Scribe. The Evidence Is Sealed.
Abridge, an ambient scribe startup, markets itself as patient-focused. STAT News investigates whether the claim holds up when clinical outcomes data sits behind paywalls.
1 in 8 startups in YC's Winter 2026 batch build physical AI robots
Y Combinator's latest cohort shows a sharp pivot: 25 companies focused on physical systems, infrastructure, and robotics data. Here's what the concentration means for hardware founders.
Gartner Sydney Summit: Data Leaders Gather for 2026 Outlook
Gartner's Data & Analytics Summit convenes in Sydney. Day 1 covered industry trends, vendor announcements, and strategic priorities for enterprise data teams in 2026.
Gartner adds Galileo to enterprise software reviews
Gartner has included Galileo in its enterprise software and services assessment. Learn what criteria shaped the ranking and what it means for vendor comparison.